Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Improved Patient Satisfaction, Adherence and Health-Related Quality of Life with Deferasirox (Exjade®) in β-Thalassemia Patients Previously Receiving Other Iron Chelation Therapies.

John B. Porter, Miranda Athanasiou-Metaxa, Donald K. Bowden, Jacques Troncy, Dany Habr, Gabor Domokos, Bernard Roubert, Diana Rofail, Adam Gater, Jean-François Baladi, M. Domenica Cappellini

Blood (2009) 114 (22): 2486.

https://doi.org/10.1182/blood.V114.22.2486.2486

Published: 2009

Journal Articles

Need of Reconsideration of Mobilization Strategy in Autologous Stem Cell Transplantation for Multiple Myeloma: Results of the Positive Impact of High Number of CD34+ Infused Cells.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M, Benjamin Riche, PhD, Franck Emmanuel Nicolini, MD, PhD, Nicole Raus, Fiorenza Baracco, MD, Giovanna Cannas, MD, Youcef Chelghoum, MD, Emmanuelle Nicolas-Vierlizier, MD, Gilles Clapisson, Xavier Thomas, MD, Phd, Jacques Troncy, MD, Amina Zinai, DMD, MD, René Ecochard, PhD, Sophie Ducastelle, MD

Blood (2009) 114 (22): 3225.

https://doi.org/10.1182/blood.V114.22.3225.3225

Published: 2009

Journal Articles

Impact of Molecular Markers and Cytogenetic Abnormalities on Long-Term Overall Survival and Disease-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Myeloid Leukemia (AML) patients

Mauricette Michallet, MD, PhD, Mohamad Sobh, PhD, Xavier Thomas, MD, Carole Charlot, Fiorenza Barraco, MD, Giovanna Cannas, MD, Franck E Nicolini, MD, PhD, Emmanuelle Nicolas-virelizier, MD, Claudiu Plesa, MD, Youcef Chelghoum, MD, Jacques Troncy, MD, jean-Pierre Magaud, MD, PhD, Isabelle Tigaud, Sandrine Hayette

Blood (2008) 112 (11): 4476.

https://doi.org/10.1182/blood.V112.11.4476.4476

Published: 2008

Journal Articles

Impact of Pre-Transplantation, Mobilization and Graft Variables on Transplant Outcome after Autologus Hematopoietic Stem Cell Transplantation in Multiple Myeloma in Patients

Mauricette Michallet, MD, PhD, Quoc Hung Le, MD, Mohamad Sobh, PhD, Nicole Raus, Melissa Clarck, Jean Vial, Gilles Clapisson, Carole Paillet, Franck E Nicolini, MD, PhD, Jacques Troncy, MD, Xavier Thomas, MD, Youcef Chelghoum, MD, Emmanuelle Nicolas-Vierlizier, MD, Giovanna Cannas, MD, Claudiu Plesa, MD, Fiorenza Baracco, MD

Blood (2008) 112 (11): 5137.

https://doi.org/10.1182/blood.V112.11.5137.5137

Published: 2008

Journal Articles

Long-Term Follow-up of Multiple Myeloma Patients Treated by Bortezomib (Velcade ® ): A Study on Efficacy, Tolerance, Survival and Time to Progression

Mauricette Michallet, MD, PhD, Mohamad Sobh, PhD, Quoc Hung Le, MD, Fiorenza Barraco, MD, Charles Dumontet, MD, PhD, Youcef Chelghoum, MD, Emmanuelle Nicolas-Virelizier, MD, Xavier Thomas, MD, Aline Praire, Claudiu Plesa, MD, Giovanna Cannas, MD, Franck Emmanuel Nicolini, MD, PhD, Jacques Troncy, MD

Blood (2008) 112 (11): 5197.

https://doi.org/10.1182/blood.V112.11.5197.5197

Published: 2008

Journal Articles

Impact of Infused Peripheral Blood Stem Cell Parameters (Total Nucleated Cells, CD34+ Cells, CD3+ Cells and CFU-GM) on Transplant Outcome after Reduced Intensity Allogeneic HSCT.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Anne Thiebaut, MD, Sophie Ducastelle, MD, Nicole Raus, Daniela Revesz, MD, Jacques Troncy, MD, Youcef Chelgoum, MD, Jean-Paul Bourgeot, Philippe Dubost, Olivier Hequet, MD PhD, Franck E. Nicolini, MD PhD

Blood (2007) 110 (11): 3048.

https://doi.org/10.1182/blood.V110.11.3048.3048

Published: 2007

Journal Articles

Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience.

Claudiu Plesa, MD, Quoc-Hung Le, MD, Youcef Chelghoum, MD, Mohamed Elhamri, PhD, Isabelle Tigaud, MD, Bruno Anglaret, MD, Sophie Ducastelle, MD, Marie-Claire Perrin, MD, Frank Nicolini, MD, Amine Belhabri, MD, Jacques Troncy, MD, Anne Thiebaut, MD, Daniela Revesz, MD, Eric Wattel, MD, Charles Dumontet, MD, Mauricette Michallet, MD, Xavier Thomas, MD

Blood (2007) 110 (11): 4352.

https://doi.org/10.1182/blood.V110.11.4352.4352

Published: 2007

Journal Articles

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Blood (2006) 107 (4): 1292–1298.

https://doi.org/10.1182/blood-2005-04-1588

Published: 2006

Journal Articles

Bortezomib Therapy for Multiple Myeloma in Relapse after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RICT).

Sophie Ducastelle, MD, Daniela Revesz, MD, Jacques Troncy, MD, Samira Mahmoudi, MD, Xavier Thomas, MD, PhD, Anne Thiebaut, MD, Franck E. Nicolini, MD, PhD, Emmanuelle Tavernier, MD, Quoc-Hung Le, MD, Youssef Chelgoum, MD, Aline Praire, Mauricette Michallet, MD, PhD

Blood (2005) 106 (11): 5399.

https://doi.org/10.1182/blood.V106.11.5399.5399

Published: 2005

Journal Articles

Gemtuzumab Ozogamicin (Mylotarg ® ) as Single Agent Treatment for Adult Patients with Acute Myeloid Leukemia (AML).

Xavier Thomas, Quoc-Hung Le, Emmanuelle Tavernier, Samira Mahmoudi, Youcef Chelghoum, Franck Nicolini, Anne Thiebaut, Jacques Troncy, Daniela Revesz, Mohamed Elhamri, Mauricette Michallet

Blood (2005) 106 (11): 4598.

https://doi.org/10.1182/blood.V106.11.4598.4598

Published: 2005

Journal Articles

Impact of Peripheral Blood Stem Cell Recruitment on Outcome of Single or Double Autologous Hematopoietic stem Cell Transplantation for Multiple Myeloma.

Mauricette Michallet, MD PhD, Quoc-Hung Le, MD, Anne-Sophie Michallet, MD, Anne Thiebaut, MD, Emmanuelle Tavernier, MD, Jacques Troncy, MD, Xavier Thomas, MD PhD, Youcef Chelghoum, MD, Aline Praire, Elodie Gadolet, Franck E. Nicolini, MD PhD, Gilles Clapisson, Irene Philip, MD

Blood (2004) 104 (11): 5221.

https://doi.org/10.1182/blood.V104.11.5221.5221

Published: 2004

Journal Articles

Donor Lymphocyte Infusion Management and Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Anne-Sophie Michallet, MD, Anne Thiebaut, MD, Emannuelle Tavernier, MD, Hanadi Rafii, MD, Daniela Revesz, MD, Jacques Troncy, MD, Aline Praire, Elodie Gadolet, Valerie Dubois, PhD, Lucette Gebuhrer, MD, Olivier Hequet, MD, PhD, Jean-Paul Bourgeot, Franck E. Nicolini, MD, PhD

Blood (2004) 104 (11): 2305.

https://doi.org/10.1182/blood.V104.11.2305.2305

Published: 2004

Journal Articles

Randomized Clinical Trial Comparing Melphalan-Prednisone (MP), MP-Thalidomide (MP-THAL) and High-Dose Therapy Using Melphalan 100 MG/M 2 (MEL100) for Newly Diagnosed Myeloma Patients Aged 65–75 Years. Interim Analysis of the IFM 99-06 Trial on 350 Patients.

Thierry Facon, Jean Yves Mary, Cyril Hulin, Lofti Benboubker, Michel Attal, Jean Luc Harousseau, Brigitte Pegourie, Marc Renaud, Gaelle Guillerm, Laurent Voillat, Carine Chaleteix, Jacques Troncy, Mathieu Monconduit, Philippe Casassus, Herve Maisonneuve, Veronique Dorvaux, Jerome Jaubert, Mamoun Dib, Chantal Doyen

Blood (2004) 104 (11): 206.

https://doi.org/10.1182/blood.V104.11.206.206

Published: 2004

Journal Articles

Bortezomib (VELCADE®) Plus Dexamethasone as Induction Treatment Prior to Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: Preliminary Results of an IFM Phase II Study.

Jean-Luc Harousseau, MD, Michel Attal, MD, Xavier Leleu, MD, Remy Gressin, MD, Cyrille Hulin, MD, Jean-Gabriel Fuzibet, MD, Jacques Troncy, MD

Blood (2004) 104 (11): 1490.

https://doi.org/10.1182/blood.V104.11.1490.1490

Published: 2004

Journal Articles

Comparison of Na 18 F and 18 F-Deoxyglucose Positron Emission Tomography in Patients with Multiple Myeloma.

Jacques Troncy, MD, Sylvie Mercier, MD, Pascal Roy, MD, Mauricette Michallet, MD, Charles M. Dumontet, MD, Marc Janier, MD

Blood (2004) 104 (11): 3457.

https://doi.org/10.1182/blood.V104.11.3457.3457

Published: 2004

NARROW

Improved Patient Satisfaction, Adherence and Health-Related Quality of Life with Deferasirox (Exjade®) in β-Thalassemia Patients Previously Receiving Other Iron Chelation Therapies.

Need of Reconsideration of Mobilization Strategy in Autologous Stem Cell Transplantation for Multiple Myeloma: Results of the Positive Impact of High Number of CD34+ Infused Cells.

Impact of Molecular Markers and Cytogenetic Abnormalities on Long-Term Overall Survival and Disease-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Myeloid Leukemia (AML) patients

Impact of Pre-Transplantation, Mobilization and Graft Variables on Transplant Outcome after Autologus Hematopoietic Stem Cell Transplantation in Multiple Myeloma in Patients

Long-Term Follow-up of Multiple Myeloma Patients Treated by Bortezomib (Velcade ® ): A Study on Efficacy, Tolerance, Survival and Time to Progression

Impact of Infused Peripheral Blood Stem Cell Parameters (Total Nucleated Cells, CD34+ Cells, CD3+ Cells and CFU-GM) on Transplant Outcome after Reduced Intensity Allogeneic HSCT.

Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience.

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Bortezomib Therapy for Multiple Myeloma in Relapse after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RICT).

Gemtuzumab Ozogamicin (Mylotarg ® ) as Single Agent Treatment for Adult Patients with Acute Myeloid Leukemia (AML).

Impact of Peripheral Blood Stem Cell Recruitment on Outcome of Single or Double Autologous Hematopoietic stem Cell Transplantation for Multiple Myeloma.

Donor Lymphocyte Infusion Management and Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

Randomized Clinical Trial Comparing Melphalan-Prednisone (MP), MP-Thalidomide (MP-THAL) and High-Dose Therapy Using Melphalan 100 MG/M 2 (MEL100) for Newly Diagnosed Myeloma Patients Aged 65–75 Years. Interim Analysis of the IFM 99-06 Trial on 350 Patients.

Bortezomib (VELCADE®) Plus Dexamethasone as Induction Treatment Prior to Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: Preliminary Results of an IFM Phase II Study.

Comparison of Na 18 F and 18 F-Deoxyglucose Positron Emission Tomography in Patients with Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only